Pharmacokinetics of huperzine A following oral administration to human volunteers

The objective of the present study was to investigate the in vivo pharmacokinetics of huperzine A in healthy human volunteers. Twelve subjects (M 6, F 6; age ranged from 20-25 years) participated in the study. Huperzine A was administered in tablet form at a single dose of 0.4 mg. Following oral adm...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of drug metabolism and pharmacokinetics Vol. 32; no. 4; pp. 183 - 187
Main Authors Li, Y. X., Zhang, R. Q., Li, C. R., Jiang, X. H.
Format Journal Article
LanguageEnglish
Published Genève Médecine et hygiène 01.10.2007
Subjects
Online AccessGet full text
ISSN0378-7966
2107-0180
DOI10.1007/BF03191002

Cover

More Information
Summary:The objective of the present study was to investigate the in vivo pharmacokinetics of huperzine A in healthy human volunteers. Twelve subjects (M 6, F 6; age ranged from 20-25 years) participated in the study. Huperzine A was administered in tablet form at a single dose of 0.4 mg. Following oral administration, the presence of huperzine A started to appear in the plasma at 5-10 min, and reached the peak concentrations with a Cmax of 2.59 +/- 0.37 ng/ml at 58.33 +/- 3.89 min (time to reach peak level, Tmax. The area under plasma vs time curve (AUC(0-t)) and the area under plasma from zero to infinity (AUC(0-infinity) for huperzine A were found to be 1986.96 +/- 164.57 microg/l.min and 2450.34 +/- 233.32 microg/l.min, respectively. The results of this study indicated that the pharmacokinetics of huperzine A conformed to a two-compartmental open model. The mean values of alpha and the beta half-life were 21.13 +/- 7.28 min and 716.25 +/- 130.18 min respectively, and showed a biphasic profile with rapid distribution followed by a slower elimination rate.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0378-7966
2107-0180
DOI:10.1007/BF03191002